Current methods rely on surgery to find out if a man has viable sperm that can be retrieved for fertility treatment.
The new non-invasive test has identified two bio-markers in sperm, which can be used to predict whether sperm retrieval will be successful, 'BBC News' reported.
Male infertility is responsible for about half of cases of infertility.
Fertility treatment can sometimes help men who produce no sperm to father a biological child if they have normal sperm that can be extracted surgically.
Using current technology, the only way to find out if a man has viable sperm is to carry out surgery to look for sperm in the testes.
The study suggests two bio-markers can identify who will benefit from surgery, the report said.
The holy grail of the new research was to find a way to help men avoid unnecessary testicular biopsies, said Dr Keith Jarvi of the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto, Canada.
The study was published in the journal Science Translational Medicine.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
